HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two unusual cases of intractable hyperthyroidism responsive to octreotide: Munchausen syndrome or not?

AbstractBACKGROUND:
The effective treatment for patients with resistant hyperthyroidism is difficult.
METHODS:
In this case report with 4-year follow-up data, we present 2 unusual cases of hyperthyroidism that were unresponsive to almost all antithyroid treatments including total thyroidectomy, but both were controlled with octreotide.
RESULTS:
Cases 1 and 2 were both middle-aged women. They presented thyrotoxicosis with a low serum concentration of TSH and thyroidal radioactive iodine uptake (RAIU). The underlying causes, such as thyroiditis, metastatic thyroid cancer and struma ovarii were explored. Iodine-induced hyperthyroidism, particularly factitious hyperthyroidism was highly suspected, but there was no direct evidence to establish these diagnoses. In spite of good compliance, their thyrotoxicosis could not be controlled with large doses of PTU or MMI. β-blocker, methylprednisolone, radio-iodine therapy and even thyroidectomy were all attempted and failed. Short-acting octreotide was first administered to case 1 and then to case 2. Thyroid function improved greatly within 3 days in both cases. The doses of octreotide were tapered down to twice a week with consistent efficacy. During the follow-up periods, case 1 required octreotide 0.1mg twice per week and case 2 is on thyroid replacement therapy due to hypothyroidism. The recurrences of hyperthyroidism in both cases were again rapidly controlled with the increased dose of octreotide in case 1 and re-started the usage of octreotide in case 2.
CONCLUSIONS:
The etiology of thyrotoxicosis in these 2 cases is not clear. In the absence of struma ovarii or wide-spread follicular thyroid cancer, factitious hyperthyroidism due to Munchausen syndrome should be considered first. The efficacy of the off-label use of octreotide in hyperthyroidism was highly effective (only) in these 2 cases.
AuthorsJian-Min Liu, Li-Qun Gu, Lin Zhao, Zheng-Yi Tang, Li-Hao Sun, Jie Hong, Wei-Qing Wang, Bang-Yao Luo, Yong-Ju Zhao, Man-Yin Xu, Xi Chen, Xu-Feng Jiang, Chen-Mo Zhu, Xiao-Long Jin, Hong-Zhuan Chen, Yu-Yan Tan, Guang Ning, Jia-Lun Chen
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 412 Issue 11-12 Pg. 1155-60 (May 12 2011) ISSN: 1873-3492 [Electronic] Netherlands
PMID21376025 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2011 Elsevier B.V. All rights reserved.
Chemical References
  • Octreotide
Topics
  • Adult
  • Female
  • Humans
  • Hyperthyroidism (complications, drug therapy, pathology, physiopathology)
  • Munchausen Syndrome (complications)
  • Octreotide (therapeutic use)
  • Thyroidectomy
  • Time Factors
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: